- Lobbying
- Lobbying by Novartis Corporation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Kris Ekdahl | Intern, Rep Emanuel |
Scott Parven | Leg asst, Rep Mavroules |
Caryn Dyson | Prof staff mbr to Sen Breaux, 2003-04; Intrn to Sen Mikulski, 1999 |
Vic Fazio | Mbr of Cong, 1979-98 |
Charlie Johnson | Law clrk, H Comm on Jud, May 92-Aug 92 |
Jamie Tucker | Leg cnsl to Rep Northup, 1999; leg cnsl to Rep Inglis, 1997-99; legal intern to Spkr Gingrich, 1996; leg aide to Sen Coverdell, 1993-94 |
Francine Friedman | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Educate members of congress and the administration regarding the importance of vaccines.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate